| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
1989-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0daf759845ca7b34cdffae313df0845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eddf74432a7ada6bdd8f17dec54bf512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818000bee44d76d0163c01eca35b67b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5e739e875f91fd3ea48c6cb1e0435c |
| publicationDate |
1989-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0347105-A2 |
| titleOfInvention |
S-sulfonated calcitonin derivatives |
| abstract |
Calcitonin derivatives wherein at least one of the first cysteine residue and the seventh cysteine residue is S-sulfonated; processes for the production of the calcitonin derivatives comprising the steps of reacting a calcitonin with a sulfite anion or both a sulfite anion and an oxidizing agent to form the S-sulfonated derivative, and recovering the sulfonated calcitonin derivative; a pharmaceutical composition comprising the S-sulfonated calcitonin derivative; and a method of treating a patient having a disease wherein a decrease of a serum calcium level is desired, by administering the S-sulfonated calcitonin derivative to the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479032-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10174082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6509001-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6086850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6034064-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083480-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9624618-A1 |
| priorityDate |
1988-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |